Original research
par
Brothers, Thomas D. et al
Date de publication
2022
Géographie
Canada
Langue de la ressource
English
Texte disponible en version intégrale
Oui
Open Access / OK to Reproduce
Non
Évalué par des pairs
Yes
L’objectif
We aimed to assess the uptake of slow-release oral morphine (SROM) as second-line OAT among medically ill, hospitalised patients who declined buprenorphine and methadone.
Constatations/points à retenir
The ability to offer SROM (in addition to buprenorphine or methadone) increased rates of OAT initiation among hospitalised patients. Increasing access to SROM would help narrow the opioid use disorder treatment gap of unmet need.
La conception ou méthodologie de recherche
Hospitalised patients with untreated moderate-to-severe opioid use disorder referred to an inpatient addiction medicine consultation service, between June 2018 and September 2019, in Nova Scotia, Canada (n=34)
Mots clés
About PWUD
Outcomes
Chronic pain
Substitution/OAT
Hospitals
